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The current mixture risk assessment
methodologies do not facilitate the use of
data on interaction mechanisms in a quantita-
tive manner (1,2). The pharmacokinetic and
pharmacodynamic interactions can lead to
lower toxicity (antagonism) or greater toxicity
(synergism, potentiation) of mixtures than
that expected based on the knowledge of the
potency and dose of the mixture constituents
(3). The pharmacokinetic interactions lead to
a change in tissue dose of chemicals during
mixture exposures compared with single
exposures and represent the most common
type of interaction observed and reported in
the literature (3,4). The extent of the change
in tissue dose of chemicals resulting from
pharmacokinetic interactions during mixture
exposures depends on the concentrations of
all components and the mechanism(s) of
interactions.
The pharmacokinetic interactions,
particularly metabolic interactions, between
chemicals have usually been studied under in
vitro or in vivo situations (3). Binary-level
interactions at the pharmacokinetic level have
been described using physiologically based
models (5–9). Basically, these physiologically
based pharmacokinetic (PBPK) models
describe the organism as a set of tissue com-
partments interconnected by systemic circula-
tion, and describe the chemical uptake,
distribution, metabolism, and excretion with
algebraic and differential equations (10). In
binary mixtures, the PBPK models for the two
chemicals are interconnected at the level of the
tissue compartment where the interaction is
hypothesized or shown to occur (Figure 1). In
the binary chemical PBPK model, two sets of
identical equations are used, one for each
chemical, along with an equation that speciﬁ-
cally accounts for the interactions (e.g., com-
petitive inhibition for metabolism in liver,
induction of hepatic metabolism) (4–5). The
latter equation provides the interconnection
between the two chemicals circulating at the
same time within the unified PBPK model.
This modeling framework has been used suc-
cessfully for elucidating the mechanism of
interactions (5,7,8), and also for conducting
extrapolations (e.g., high dose to low dose, rat
to human) of the magnitude of interactions
based on mechanistic considerations (6,11,12).
Despite the availability of PBPK models
for conducting extrapolations of the occur-
rence and magnitude of interactions from lab-
oratory studies to exposure scenarios of interest
(11–13), the data on binary chemical interac-
tions have not been used in risk assessment.
The primary reason is that the data on binary
interactions provide only an incomplete pic-
ture of interactions potentially occurring
within a complex mixture. Further, there is
uncertainty regarding the magnitude and
direction of the influence of other mixture
components on the interacting chemicals and
the binary interaction itself. PBPK models are
potentially useful tools for extrapolating the
magnitude of interactions from binary to more
complex mixtures, based on mechanistic
considerations. This article provides an
overview of the conceptual basis and validity of
PBPK models for extrapolating the occurrence
and magnitude of interactions from binary to
more complex chemical mixtures. The descrip-
tions of conceptual basis and validation studies
presented in this article relate to mixtures of
volatile organic chemicals (VOCs) in which
the components interact by competitive inhi-
bition for hepatic metabolism. The reasoning
and methodology outlined below should be
applicable to other mixtures and interaction
mechanisms, provided the required data are
available or can be generated.
Extrapolation of Interactions
from Binary to More Complex
Mixtures
Conceptual basis. In a binary chemical PBPK
model, the rate of metabolism of each chemi-
cal is calculated using a Michaelis-Menten
equation along with a modulation factor
reﬂecting the effect of interaction (e.g., com-
petitive inhibition) (Figure 2). Both chemicals,
by competing with each other for the finite
number of binding sites, mutually inhibit their
metabolism (9). The resulting change in the
metabolism rate of one chemical (RAM1) is a
function of a) its Michaelis-Menten constants
(Vmax
1, [maximum velocity] and Km1), b) its
concentration at the site of metabolism (C1),
c) the concentration of the competing chemi-
cal at the site of metabolism (C2), and d) the
inhibition constant Ki21, which reﬂects the C2
at which 50% inhibition occurs:
[1]
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Chemical Mixtures
The available data on binary interactions are yet to be considered within the context of mixture
risk assessment because of our inability to predict the effect of a third or a fourth chemical in the
mixture on the interacting binary pairs. Physiologically based pharmacokinetic (PBPK) models
represent a potentially useful framework for predicting the consequences of interactions in mix-
tures of increasing complexity. This article highlights the conceptual basis and validity of PBPK
models for extrapolating the occurrence and magnitude of interactions from binary to more com-
plex chemical mixtures. The methodology involves the development of PBPK models for all mix-
ture components and interconnecting them at the level of the tissue where the interaction is
occurring. Once all component models are interconnected at the binary level, the PBPK frame-
work simulates the kinetics of all mixture components, accounting for the interactions occurring
at various levels in more complex mixtures. This aspect was validated by comparing the simula-
tions of a binary interaction–based PBPK model with experimental data on the inhalation kinetics
of m-xylene, toluene, ethyl benzene, dichloromethane, and benzene in mixtures of varying compo-
sition and complexity. The ability to predict the kinetics of chemicals in complex mixtures by
accounting for binary interactions alone within a PBPK model is a significant step toward the
development of interaction-based risk assessment for chemical mixtures. Key words: mixtures,
interactions, PBPK modeling. Environ Health Perspect 110(suppl 6):989–994 (2002).
http://ehpnet1.niehs.nih.gov/docs/2002/suppl-6/989-994krishnan/abstract.html
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If there is metabolic inhibition resulting in a
significant decrease in RAM of a chemical
during mixed exposures compared with that
during individual exposures, then this will
frequently lead to an increase in the blood
concentration of unchanged parent chemi-
cals. The toxicological consequence of such a
change in the parent chemical concentration
(i.e., increase) or metabolite production (i.e.,
decrease) depends on which one of these is
related to the mode of action of the chemical
in mixtures. Incorporating Equation 1 within
PBPK models, the change in the rate of
metabolism and the ensuing modulation of
the tissue concentrations of chemicals in
binary mixtures can be simulated. But what
happens when the organism is simultaneously
exposed to a third or a fourth chemical? How
will the other, newer mixture constituents
affect the binary interaction between the ﬁrst
two chemicals? The PBPK models are
uniquely useful in addressing these questions.
PBPK models facilitate the extrapolation
of the occurrence and magnitude of interac-
tions from binary to more complex chemical
mixtures on the basis of interaction mecha-
nisms elucidated at binary levels. The calcula-
tion of RAM1 in the presence of several
competitive inhibitors can be accomplished
using Equation 1 with one modiﬁcation, i.e.,
adding to C2/Ki21 in the denominator the sum
of Cn/Kin1, representing the effect of each of
the inhibitor that interacts with the substrate:
[2]
The above equation for calculating RAM in
PBPK models then requires only data on
binary interactions involving the substrate and
each of the inhibitors to predict the conse-
quences in more complex mixture situations.
This suggests that binary interaction data can
actually be used as the building blocks for mix-
ture modeling. According to this conceptual
basis, PBPK models for mixtures of any com-
plexity can be created, as long as the quantita-
tive information on the mechanism of
interaction for each interacting pair (e.g., Ki) is
available or can be hypothesized. In a mixture
of three chemicals (A, B, C), for example, there
are three sets of binary interactions (AB, BC,
AC) forming an interconnected network
(Figure 3). Here, the concentrations of chemi-
cal A and chemical B, along with their inhibi-
tion constants (KiAB; KiBA), determine the
outcome of the binary interaction AB. With
the addition of chemical C to this binary mix-
ture, all one has to do is to estimate the binary-
level interaction constants representing
metabolic interactions between A and C, and
B and C. Chemical C not only interacts
directly with chemicals A and B but also
indirectly inﬂuences the interaction between
chemicals A and B by inhibiting their
metabolism (Figure 3).
For moving from binary to more complex
mixtures, the first step is to create PBPK
models for each mixture component, then
these single-chemical models should be inter-
connected at the binary level (Figure 4). If we
consider competitive metabolic inhibition as
the mechanism of interaction, then the equa-
tion for calculating the RAM for each mix-
ture component should be modified
appropriately (e.g., Equation 2). Assuming
that a PBPK model exists for each mixture
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Figure 2. Functional representation of a PBPK model for a binary mixture of VOCs. Interactions between
components 1 and 2 of this mixture occur at the level of hepatic metabolism. Ci and Calv refer to inhaled
and alveolar air concentrations. Cv and Ca refer to venous and arterial blood concentrations. Cvi and Qi
refer to venous blood concentrations leaving tissue compartments and blood flow to tissues (i.e., f, adi-
pose tissue; s, slowly perfused tissues; r, richly perfused tissues; and l, liver). Kiij is the constant describing
competitive inhibition of the metabolism of chemical j by chemical i. Vmax is the maximal velocity of
metabolism. Km is the Michaelis afﬁnity constant and RAM is the rate of the amount metabolized.
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Figure 3. Interactions among the components of a
ternary mixture. KiXY refers to the interactive effect
of chemical X on chemical Y.
Figure 1. Conceptual representation of a PBPK
model for a binary mixture of VOCs. Here, the
models for the individual chemicals (A, B) are inter-
connected at the metabolic level in the liver by
modifying the RAM according to the interaction
mechanism involved.
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component, logically the proposed modeling
approach should be applicable for extrapola-
tion to mixtures of any complexity. It is
important to note that all linkages involving
mixture components need be only of binary
nature (Figure 4).
In the PBPK models, if we include
information on interactions at the binary
level alone, how is it possible to simulate the
consequences of interactions in more complex
mixtures? Let us assume that the binary
chemical interaction between A and B has
been modeled. After the addition of chemical
C, the PBPK model simulates not only the
consequence of binary interactions involving
C (i.e., C–A, C–B) but also the modulatory
effect of C on the interaction between A and
B. Once we describe the inhibitory effect of
C on B, this would result in a reduction in
the rate of B metabolized and consequently
an increase in its concentration in venous
blood leaving the liver (CvlB). CvlB, in turn, is
the numerator of the term representing the
inhibitory effect of B on A (i.e., 1 +
CvlB/KiBA). Because the exposure to chemical
C increases CvlB, this then translates to a
modiﬁcation of the magnitude of the interac-
tive effect of B on A. Similarly, C may also
affect the concentration of A, which would
influence the magnitude of the interactive
effect of A on B. The PBPK model frame-
work can also simulate similar phenomena
affecting the concentration of C, as all com-
ponents of the mixture are linked (Figure 3).
Based on this analogy, it is possible to predict
the inﬂuence of the addition of chemical D to
the ternary mixture, and so forth. When a
fourth chemical, D, is added to existing
ternary mixture PBPK model of chemicals A,
B, and C, we need to consider only three
Chemical Mixtures • PBPK modeling of mixtures
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Figure 4. Conceptual representation of a PBPK model for a mixture of ﬁve VOCs. Here the models for the
individual chemicals (A, B, C, D, E) are interconnected at the metabolic level in the liver by modifying the RAM
according to the interaction mechanism involved. Note that all interconnections are at the binary level only.
Figure 5. Comparison of the PBPK model simulations of venous blood
concentrations of TOL after a 4-hr inhalation exposure to 100 (A) and 200 (B)
ppm TOL alone or in combination with EBZ or m-XYL. Reproduced from Tardif
et al. (14) with permission from Academic Press.
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Figure 6. Comparison of the PBPK model simulations of venous blood
concentrations of m-XYL after a 4-hr inhalation exposure to 100 (A) and 200 (B)
ppm m-XYL alone or in combination with EBZ or TOL. Reproduced from Tardif
et al. (14) with permission from Academic Press.
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0 123456binary-level interactions additionally (i.e.,
D–A, D–B, D–C). By doing this, the modula-
tory effect of D on C–A, B–A, and B–C inter-
actions will be automatically simulated, as all
components are linked with each other within
the PBPK framework. The effect of D on the
kinetics of A will in turn affect the A–C and
A–B interactions. Basically, each new binary
interaction will affect the kinetics of other
chemicals that are part of the network of
binary interactions already present in the mix-
ture. The same considerations are applicable
while another chemical, E, is added to the
quaternary mixture. With the characterization
of four new binary interactions, chemical E
becomes an integral part of the network of the
components of the mixture, and any modula-
tion of a binary interaction involving E will
have repercussions on all the others (Figure 4).
The novel aspect of this approach is that it
requires only data on binary interaction mech-
anisms for predicting the magnitude and con-
sequences of multiple interactions within
complex mixtures. The validation of the
PBPK modeling approach for extrapolation of
interactions from binary to more complex
mixtures has been accomplished using mix-
tures containing benzene (BEN), toluene
(TOL), m-xylene (m-XYL), ethyl benzene
(EBZ), and dichloromethane (DCM).
Validation. The validation of the PBPK
modeling approach outlined above has been
accomplished in a limited number of studies
using mixtures of VOCs (12–16). The overall
approach in these studies involved the charac-
terization of the kinetics of chemicals present
individually or in binary mixtures for identi-
fying the occurrence and magnitude of binary
interactions (e.g., competitive inhibition) as
well as for determining the quantitative
nature of the interaction mechanism (e.g.,
Ki). The models for the various individual
chemicals were then interconnected at the
binary level on the basis of the interaction
mechanism (Figure 4). The model was then
able to simulate the kinetics of each chemical
in the presence of other chemicals, based
solely on binary-level interactions that are
interconnected within the PBPK model.
Figure 5 compares the kinetics of TOL in
rats exposed for 4 hr to 100 or 200 ppm TOL
alone or in the presence of 100 or 200 ppm m-
XYL or EBZ. Similar data obtained for m-XYL
are presented in Figure 6. The PBPK models
incorporating inhibition constants for compe-
tition of hepatic metabolism (13,14) ade-
quately simulated the modulated kinetics of
TOL and m-XYL in various binary mixtures
(Figures 5, 6). The difference in kinetics
between single and combined exposures is
essentially a function of the modulated venous
blood concentrations of both chemicals and
the magnitude of the Ki. When rats are
exposed to all three chemicals together (i.e.,
TOL, m-XYL, and EBZ at 100 ppm each),
interaction effects on TOL are even greater
than in the binary mixtures (Figure 5A vs
Figure 7A); EBZ further increases the
unchanged concentrations of TOL not only
because EBZ interferes directly with the
metabolism of TOL but also because it
inhibits m-XYL metabolism, increases its
unchanged concentrations, and thus enhances
its inhibitory effect on TOL. Such observa-
tions can be made for m-XYL as well (Figure
6A vs Figure 7B). To obtain the simulations
presented in Figure 7, a) the inhibition terms
and constants for the two binary interactions
EBZ-TOL and EBZ-XYL and b) the PBPK
model for EBZ were added to the existing
TOL-XYL model (13,14). For simulating the
kinetics of EBZ, TOL, and XYL in the pres-
ence of other chemicals such as DCM and
BEN, one had simply to estimate the binary-
level interaction constants (Table 1) for the
additional pairs (DCM-BEN, DCM-TOL,
DCM-XYL, DCM-EBZ, BEN-TOL, BEN-
XYL, and BEN-EBZ) and obtain the PBPK
models for DCM and BEN for incorporation
within the existing TOL-EBZ-XYL PBPK
model (14–16). The resulting model simulates
the kinetics of TOL, EBZ, XYL, DCM, or
BEN in mixtures of varying complexities and
compositions, solely on the basis of intercon-
nected information on binary-level interactions
(Figures 8, 9). In obtaining these simulations,
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Table 1. Biochemical parameters for PBPK modeling
of dichloromethane (D), benzene (B), toluene (T),
ethyl benzene (E), and m-xylene (X).a
Parameter D B T E X
Vmaxc (mg/hr/kg) 6.25 2.11 3.44 6.39 6.49
Km (mg/L) 0.75 0.10 0.13 1.04 0.45
Ki (mg/L)
αD— 0.08 0.16 0.11 0.32
αB 0.30 — 0.14 0.26 0.22
αT 0.35 0.22 — 0.17 0.33
αE 0.99 0.63 0.95 — 1.67
αX 0.45 0.23 0.36 0.51 —
α, inhibitor acting on the substrate’s metabolism. aData
from Haddad et al. (18).
Figure 7. Comparison of the simulations of venous blood concentrations of (A) TOL, (B) m-XYL, and (C) EBZ
predicted by the individual chemical model (solid lines) or a ternary chemical PBPK model (dashed lines)
with corresponding experimental data (symbols) obtained in rats exposed for 4 hr to 100 ppm of each of these
solvents alone or in combination. Reproduced from Tardif et al. (14) with permission from Academic Press.
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Figure 9. Comparison of experimental data (symbols) with PBPK model simulations (dotted lines, single-chemical model; solid lines, ﬁve-chemical mixture model)
of venous blood concentrations of DCM, BEN, TOL, EBZ, and m-XYL in rats after a 4-hr inhalation exposure. The atmospheric concentrations of the chemicals
were 100 ppm each during the single and combined exposures. Reproduced from Haddad et al. (16) with permission from Academic Press.
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Figure 10. Comparison of PBPK model simulations
(lines) with experimental data on venous blood
concentrations of m-XYL in rats after a 4-hr expo-
sure to this chemical in the presence of DCM, BEN,
trichloroethylene (TRI), TOL, tetrachloroethylene
(PER), EBZ, p-xylene (p-XYL), o-xylene (o-XYL), and
styrene (STY) in various combinations (m-XYL (50
ppm) + DCM (100 ppm) [ ]; BEN + TOL + EBZ + m-
XYL (50 ppm each) [*]; DCM (100 ppm) + TOL (50
ppm) + EBZ (50 ppm) + m-XYL (50 ppm) [+]; DCM
(100 ppm) + BEN (50 ppm) + TOL (50 ppm) + EBZ (50
ppm) + m-XYL (50 ppm) [ ]; DCM + TOL + PER +
EBZ + o-XYL + m-XYL + p-XYL + STY (50 ppm each)
[◆ ◆]; DCM + TRI + TOL + EBZ + o-XYL + m-XYL + p-
XYL + STY (50 ppm each) [■ ■]; DCM + BEN + TRI +
TOL + PER + EBZ + o-XYL + m-XYL + p-XYL + STY
(50 ppm each + preexposure) [▲ ▲]; DCM + BEN +
TRI + TOL + PER + EBZ + o-XYL + m-XYL + p-XYL +
STY (50 ppm each) [● ●]. The simulations were
obtained either using saturable metabolism
description in the single-chemical model for m-XYL
(dotted lines) or by setting hepatic extraction value
to zero in the m-XYL PBPK model (17).
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Figure 8. Comparison of experimental data (symbols) with PBPK model simulations (dotted lines, single
chemical model; solid lines, quaternary mixture model) of venous blood concentrations of BEN, TOL, EBZ,
and m-XYL in rats after a 4-hr inhalation exposure. The atmospheric concentrations of the chemicals
were 100 ppm each during the single and combined exposures. Reproduced from Haddad et al. (15) with
permission from Academic Press.
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0246no change was made to any of the equations or
model parameters used to describe the kinetics
of single chemicals or the binary interactions
within the mixture model. By specifying only
the duration and concentration of exposure to
each of the mixture constituents, their kinetics
was adequately simulated (Figure 8: 100 ppm
TOL, XYL, BEN, and EBZ for 4 hr; Figure 9:
100 ppm TOL, XYL, BEN, EBZ, and DCM
for 4 hr) (15,16).
According to this methodology, the
kinetics of chemicals in increasingly complex
mixtures can be modeled by connecting the
PBPK models of single chemicals on the
basis of the mechanisms of binary interac-
tions. The ability of this mixture-modeling
methodology to add/substitute chemicals to
the mixture without changing the preestab-
lished PBPK model structure (e.g., adding
EBZ to TOL-XYL model) is noteworthy.
Because the components of chemical mixtures
of interest may differ qualitatively or quantita-
tively, it is important to have a framework such
as this, which can be used as the foundation on
which to build. The limitation of this model-
ing approach is that all existing binary interac-
tions need to be characterized at the
mechanistic level for simulating the kinetics of
the components of complex mixtures.
However, there is no way of predicting a priori
the quantitative characteristics of these binary
interactions, and therefore they must be deter-
mined following experimentation. The
number of binary interactions in a mixture (N)
can be calculated as follows:
[3]
where n is the number of mixture components.
Considering the complexity of some of the
mixtures to which humans are exposed, it will
be tedious, if not impossible, to characterize
all existing binary interactions in every mix-
ture. In some cases, the mixture composition
is ill deﬁned such that all relevant binary inter-
actions cannot even be identiﬁed. One way of
addressing this problem, until all binary inter-
actions are characterized, would be to estimate
the theoretic limits of the modulation of
blood concentrations that would arise from
metabolic inhibitions. Accordingly, the
hepatic extraction ratio in PBPK models of
mixture components can be set to zero for
predicting the maximal limit of modulation of
blood kinetics of chemicals during mixed
exposures (17).
Figure 10 compares the PBPK model
simulations with experimental data on the
blood kinetics of m-XYL, determined after
inhalation exposure of rats for 4 hr to 50 ppm
of this chemical in increasingly complex mix-
tures containing up to nine other VOCs (17).
Of the two simulations presented in Figure 10,
the top line represents the kinetic proﬁle when
hepatic extraction ratio (E) is equal to zero,
which essentially is reﬂective of the upper limit
of the effect of metabolic inhibition. It is obvi-
ous that regardless of the number and nature
of the inhibitors present in complex mixtures,
metabolism cannot be inhibited by more than
100%. As shown by the experimental data on
m-XYL in Figure 10, with increasing number
of inhibitors in a mixture, the impact on the
blood kinetics is increasingly more important
(i.e., blood concentrations of m-XYL increase
with mixture complexity). But the increase in
blood concentration of the parent chemical
form of a substance (e.g., m-XYL), as shown in
Figure 10, cannot exceed a theoretic maximum
resulting from 100% inhibition of hepatic
metabolism.
Conclusions
The methodology reviewed in this article
facilitates the addition or substitution of
chemicals to existing mixture PBPK models
and requires that the binary interactions
between the new chemical and preexisting
mixture components be characterized. This
modeling approach will allow assessors to
predict the magnitude of toxicokinetic
interactions in mixtures of varying complexity
and composition, and in each case permit the
prediction of the extent of change in the tis-
sue dose or kinetics of the toxic moiety. The
use of this information, along with the data
on the tissue dose versus tissue response rela-
tionship for each component, should
facilitate the conduct of a toxicokinetic inter-
action-based risk assessment for mixtures
(18,19). In cases where the data on binary
interactions are lacking or impossible to
acquire, a simpler approach of considering
maximal inhibition may be used to simulate
the theoretic upper bound of the blood con-
centrations of chemicals that are likely to
result during mixed exposures. For risk analy-
sis of mixtures, the maximal impact of meta-
bolic interactions could therefore be
estimated by setting E = 0 (in cases of
metabolic inhibition) or, alternatively, by
setting  E = 1 (in cases of metabolic
induction). This conservative approach would
consider only the consequences of metabolic
interaction, which is the most common inter-
action mechanism elucidated so far (3). Such
a pragmatic approach should facilitate the
screening and prioritization of chemicals and
chemical interactions for further scrutiny to
enhance the scientiﬁc basis of the health risk
assessment of complex chemical mixtures.
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